Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder (original) (raw)
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response
Isabell Heuser
Psychiatry Research, 2008
View PDFchevron_right
Time to All-Cause Treatment Discontinuation as the Primary Outcome in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Study
Robert Rosenheck
Statistics in Biopharmaceutical Research, 2011
View PDFchevron_right
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?
Isabell Heuser
European Neuropsychopharmacology, 2011
View PDFchevron_right
When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia
George Christison
Schizophrenia Bulletin, 1991
View PDFchevron_right
The cardiovascular and respiratory health of people with schizophrenia
Richard Laugharne
Acta Psychiatrica Scandinavica, 2006
View PDFchevron_right
Aetiology and Risk Factors of Schizophrenia
Adnan Kusman
IntechOpen eBooks, 2024
View PDFchevron_right
Integrated Psychological Therapy and Treatment-Resistant Schizophrenia: Initial Findings
Stavroula Rakitzi
Psychiatry, 2019
View PDFchevron_right
Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
Diego Novick
Value in Health, 2009
View PDFchevron_right
Predictors of antipsychotic dose changes in the CATIE schizophrenia trial
Robert Rosenheck
Psychiatry Research, 2012
View PDFchevron_right
The Relationship Between Risk of Hospitalization for Schizophrenia, SES, and Cognitive Functioning
Eyal Fruchter
Schizophrenia Bulletin, 2011
View PDFchevron_right
Comparing Antipsychotic Treatments for Schizophrenia: A Health State Approach
Robert Rosenheck
Psychiatric Quarterly, 2014
View PDFchevron_right
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients
Eva Peñas Lledó
European Journal of Clinical Pharmacology, 2007
View PDFchevron_right
Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness
Gretchen Haas
Journal of Psychiatric Research, 1998
View PDFchevron_right
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
George Garibaldi
Schizophrenia Research, 2013
View PDFchevron_right
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Jari Tiihonen
JAMA Psychiatry, 2019
View PDFchevron_right
Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
Nasser Al Zain
Neuropsychiatric Disease and Treatment, 2015
View PDFchevron_right
Schizophrenia: from neurophysiological abnormalities to clinical symptoms
Fabio Ferrarelli
Frontiers in Psychology, 2015
View PDFchevron_right
cognitive impairment in patients with schizophrenia a hospital based cross sectional study
ADITI JAIN
View PDFchevron_right
Cognitive Functions and Medication Compliance in relation to Quality of Life in Persons with Schizophrenia
Manoj K U M A R Bajaj
International Journal of Indian Psychology, 2018
View PDFchevron_right
Capacity assessment and intervention in 56-yr-old man with schizophrenia
Alan Schlechter
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2008
View PDFchevron_right
Patient and family attitudes toward schizophrenia treatment
Steven Siegel
Current Psychiatry Reports, 2004
View PDFchevron_right
Does lack of improvement in the first two weeks predict treatment resistance in recent-onset psychosis?
Helio Elkis
Clinics, 2012
View PDFchevron_right
Family treatment, expressed emotion and relapse in recent onset schizophrenia
Annet M A Nugter
Psychiatry Research, 1997
View PDFchevron_right
Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics
Takefumi Suzuki
Journal of Clinical Psychopharmacology, 2018
View PDFchevron_right
What factors should we modify to promote high functioning and prevent functional decline in people with schizophrenia?
Julio Bobes
Frontiers in Psychiatry, 2023
View PDFchevron_right